LSE - Delayed Quote GBp

Polarean Imaging plc (POLX.L)

1.1750

0.0000

(0.00%)

At close: May 23 at 4:16:11 PM GMT+1

Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum

30+ studies across diverse conditions illuminate the unique value of functional lung imaging with Xenon MRIDURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging ("MRI") of the lungs, will be featured at the American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS), taking place May 16–17 at the Marriott Marquis in San Fra

GlobeNewswire 10 days ago

PLLWF
Polarean Imaging Full Year 2024 Earnings: Revenues Beat Expectations

Polarean Imaging ( LON:POLX ) Full Year 2024 Results Key Financial Results Revenue: US$3.09m (up 247% from FY 2023...

Simply Wall St. 15 days ago

PLLWF
Polarean Imaging PLC (PLLWF) (FY 2024) Earnings Call Highlights: FDA Approval and Market ...

Polarean Imaging PLC (PLLWF) secures FDA approval and expands its market reach, while navigating financial constraints and planning for future growth.

GuruFocus.com 16 days ago

PLLWF
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Simply Wall St. 2 months ago

PLLWF
Polarean and SimonMed Announce Collaboration to Advance Lung Imaging Innovation

One of the largest US outpatient medical imaging providers to introduce Xenon MRI platform to its network Polarean and SimonMed Announce Collaboration Polarean and SimonMed Announce Collaboration to Advance Lung Imaging Innovation DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging ("MRI") of the lungs, announces a strategic c

GlobeNewswire 3 months ago

PLLWF
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems

Expands accessibility for institutions utilizing GE HealthCare MRI systemsDURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s specialized MRI Chest Coil to now include GE HealthCare 3 Tesla (3T) MRI sca

GlobeNewswire 5 months ago

PLLWF
Here's Why We're Not Too Worried About Polarean Imaging's (LON:POLX) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Simply Wall St. 8 months ago

PLLWF
Appointment of Alan Huang, PhD, as Vice President of Sales

Experienced business leader with extensive commercial experience in Magnetic Resonance Imaging Alan Huang, PhD, as Vice President of Sales Experienced business leader with extensive commercial experience in MRI DURHAM, NC and LONDON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, is pleased to announce the appointment of Alan Huang, PhD as Vice

GlobeNewswire 8 months ago

PLLWF
Appointment of Chase Hall, M.D., as Chief Medical Advisor

Adds significant pulmonary expertise to help drive engagement with the medical community Chase Hall, M.D., as Chief Medical Advisor CMA adds significant pulmonary expertise to help drive engagement with the medical community DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has appointed Chase Hall, M.D., as Chief Medical Advisor. Dr. Ha

GlobeNewswire 8 months ago

PLLWF
Polarean Imaging Full Year 2023 Earnings: US$0.055 loss per share (vs US$0.066 loss in FY 2022)

Polarean Imaging ( LON:POLX ) Full Year 2023 Results Key Financial Results Revenue: US$890.9k (down 14% from FY 2022...

Simply Wall St. 10 months ago

PLLWF
Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives

Financing led by existing and new investors DURHAM, NC and LONDON, June 20, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (MRI) of the lungs, announces the closing of a $12.6 million oversubscribed financing via the Alternative Investment Market (AIM) of the London Stock Exchange. The fundraise was co-led by strategic investors NUKEM Isotopes GmbH and Bracco S.p.A., in addit

GlobeNewswire 10 months ago

PLLWF

Performance Overview

Return	POLX.L	FTSE 100 (^FTSE)
YTD	-11.32%	+6.67%
1-Year	-12.96%	+4.54%
3-Year	-97.67%	+16.03%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Polarean Imaging plc (POLX.L)

Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum

Polarean Imaging Full Year 2024 Earnings: Revenues Beat Expectations

Polarean Imaging PLC (PLLWF) (FY 2024) Earnings Call Highlights: FDA Approval and Market ...

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Polarean and SimonMed Announce Collaboration to Advance Lung Imaging Innovation

FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems

Here's Why We're Not Too Worried About Polarean Imaging's (LON:POLX) Cash Burn Situation

Appointment of Alan Huang, PhD, as Vice President of Sales

Appointment of Chase Hall, M.D., as Chief Medical Advisor

Polarean Imaging Full Year 2023 Earnings: US$0.055 loss per share (vs US$0.066 loss in FY 2022)

Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives

Performance Overview